Bacterial Virulence Proteins as Tools to Rewire Kinase Pathways in Yeast and Immune Cells

[1]  Fabian Rudolf,et al.  Transient Activation of the HOG MAPK Pathway Regulates Bimodal Gene Expression , 2011, Science.

[2]  Pascale Cossart,et al.  Pathogen-Mediated Posttranslational Modifications: A Re-emerging Field , 2010, Cell.

[3]  S. Rosenberg,et al.  Adoptive Cell Therapy: Genetic Modification to Redirect Effector Cell Specificity , 2010, Cancer journal.

[4]  Ahmad S. Khalil,et al.  Synthetic biology: applications come of age , 2010, Nature Reviews Genetics.

[5]  Wendell A. Lim,et al.  Rapid Diversification of Cell Signaling Phenotypes by Modular Domain Recombination , 2010, Science.

[6]  M. Sadelain,et al.  Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  S. Rosenberg,et al.  Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Edda Klipp,et al.  A Quantitative Study of the Hog1 MAPK Response to Fluctuating Osmotic Stress in Saccharomyces cerevisiae , 2010, PloS one.

[9]  K. Orth,et al.  Tipping the balance by manipulating post-translational modifications. , 2010, Current opinion in microbiology.

[10]  Bruce R. Blazar,et al.  Engineering lymphocyte subsets: tools, trials and tribulations , 2009, Nature Reviews Immunology.

[11]  A. Oudenaarden,et al.  A Systems-Level Analysis of Perfect Adaptation in Yeast Osmoregulation , 2009, Cell.

[12]  Priscilla E. M. Purnick,et al.  The second wave of synthetic biology: from modules to systems , 2009, Nature Reviews Molecular Cell Biology.

[13]  A. Ganser,et al.  Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. , 2009, The Lancet. Oncology.

[14]  A. Shaw,et al.  Scaffold proteins and immune-cell signalling , 2009, Nature Reviews Immunology.

[15]  Onn Brandman,et al.  Feedback Loops Shape Cellular Signals in Space and Time , 2008, Science.

[16]  M. Elowitz,et al.  Frequency-modulated nuclear localization bursts coordinate gene regulation , 2008, Nature.

[17]  Megan N. McClean,et al.  Signal processing by the HOG MAP kinase pathway , 2008, Proceedings of the National Academy of Sciences.

[18]  T. Schumacher,et al.  An Inducible Caspase 9 Safety Switch Can Halt Cell Therapy-Induced Autoimmune Disease1 , 2008, The Journal of Immunology.

[19]  C. Bashor,et al.  References and Notes Supporting Online Material Using Engineered Scaffold Interactions to Reshape Map Kinase Pathway Signaling Dynamics , 2022 .

[20]  Jerome T. Mettetal,et al.  The Frequency Dependence of Osmo-Adaptation in Saccharomyces cerevisiae , 2008, Science.

[21]  T. Blankenstein,et al.  A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer , 2008, Proceedings of the National Academy of Sciences.

[22]  Wendell A Lim,et al.  A microfluidic system for dynamic yeast cell imaging. , 2008, BioTechniques.

[23]  She Chen,et al.  Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase. , 2007, Molecular cell.

[24]  Chiara Bonini,et al.  The suicide gene therapy challenge: how to improve a successful gene therapy approach. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  She Chen,et al.  The Phosphothreonine Lyase Activity of a Bacterial Type III Effector Family , 2007, Science.

[26]  M. Starnbach,et al.  Yeast Functional Genomic Screens Lead to Identification of a Role for a Bacterial Effector in Innate Immunity Regulation , 2007, PLoS pathogens.

[27]  Dong Wook Kim,et al.  An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription of host genes involved in immune responses , 2007, Nature Immunology.

[28]  L. Banaszynski,et al.  A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules , 2006, Cell.

[29]  Y. Chien,et al.  The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation , 2005 .

[30]  James R. Johnson,et al.  Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.

[31]  A. Weiss,et al.  The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling , 2003, The Journal of cell biology.

[32]  Chen Dong,et al.  MAP kinases in the immune response. , 2002, Annual review of immunology.

[33]  Y. Chien,et al.  Suppression of T and B Lymphocyte Activation by a Yersinia pseudotuberculosis Virulence Factor, Yoph , 1999, The Journal of experimental medicine.

[34]  J. C. Clemens,et al.  Expression, purification, and physicochemical characterization of a recombinant Yersinia protein tyrosine phosphatase. , 1992, The Journal of biological chemistry.